Angel News
Angel News

Back to Homepage

12th October 2021

Imophoron raises £4m led by Octopus and Science Creates

Imophoron, a developer of a novel, next generation rapid-response vaccine platform, ADDomer(TM), to combat present and future infectious diseases, has secured £4 million in an oversubscribed fundraising round. 


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage